NovoCure (NVCR) Cash & Equivalents (2014 - 2026)
NovoCure (NVCR) reported Cash & Equivalents of $93.7 million for Q2 2026, down 37.4% from $149.62 million a year earlier but up 7.1% from the prior quarter.
Powered by 
Analysis
NovoCure (NVCR) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, NovoCure posted Cash & Equivalents of $93.55 million, down 42.9% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -16.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $163.77 million in FY2024 (-32.0%), $240.82 million in FY2023 (+108.8%), $115.33 million in FY2022 (-44.8%) and $208.8 million in FY2021 (-11.0%).
- Five-year quarterly Cash & Equivalents spans a low of $87.53 million in Q1 2026 and a high of $689.84 million in Q3 2021.
- Year over year, Cash & Equivalents has now declined in each of the last three quarters, with an average decline of 15.0% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2021 (growth of 194.2%); the low point was Q1 2025 (a decline of 72.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $87.53 million (Q1 2026), $93.55 million (Q4 2025) and $342.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | NovoCure | 1.74 Bn | -614.09 Mn | 142.48 Mn | 93.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.70 Mn |
| Mar 31, 2026 | 87.53 Mn |
| Dec 31, 2025 | 93.55 Mn |
| Sep 30, 2025 | 342.12 Mn |
| Jun 30, 2025 | 149.62 Mn |
| Mar 31, 2025 | 127.28 Mn |
| Dec 31, 2024 | 163.77 Mn |
| Sep 30, 2024 | 185.42 Mn |
| Jun 30, 2024 | 164.80 Mn |
| Mar 31, 2024 | 453.76 Mn |
| Dec 31, 2023 | 240.82 Mn |
| Sep 30, 2023 | 154.86 Mn |
| Jun 30, 2023 | 156.98 Mn |
| Mar 31, 2023 | 185.96 Mn |
| Dec 31, 2022 | 115.33 Mn |
| Sep 30, 2022 | 243.81 Mn |
| Jun 30, 2022 | 367.01 Mn |
| Mar 31, 2022 | 190.74 Mn |
| Dec 31, 2021 | 208.80 Mn |
| Sep 30, 2021 | 689.84 Mn |
API Access
NovoCure Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NVCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NVCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NVCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();